quantisnow
FeedTopReportsPricing
⌘K
Live feed
18:14:16·261d
INSIDERFiling
Blade Air Mobility Inc. logo

Director Lerer Kenneth B was granted 35,534 shares, increasing direct ownership by 27% to 165,964 units (SEC Form 4)

BLDE· Blade Air Mobility Inc.
Consumer Discretionary
Original source

Companies

  • BLDE
    Blade Air Mobility Inc.
    Consumer Discretionary

Recent analyst ratings

  • Feb 26UpdateLake Street$6.50
  • Jul 18UpdateLadenburg Thalmann$13.00
  • Jul 17UpdateLadenburg Thalmann$13.00
  • Sep 28UpdateOppenheimer$14.00
  • Sep 9UpdateJP Morgan$16.00
  • Sep 2UpdateDeutsche Bank$15.00

Related

  • PR205d
    Strata Announces 2025 Investor Day
  • PR219d
    Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services
  • INSIDER232d
    Director Wiesenthal Robert S was granted 40,607 shares, increasing direct ownership by 0.78% to 5,275,662 units (SEC Form 4)
  • INSIDER232d
    Chief Accounting Officer Cohen Amir was granted 11,844 shares, increasing direct ownership by 13% to 103,760 units (SEC Form 4)
  • INSIDER232d
    Director Lauck Andrew was granted 11,844 shares, increasing direct ownership by 10% to 130,642 units (SEC Form 4)
  • PR237d
    Strata Critical Medical to Present at the 2025 Jefferies Industrials Conference
  • SEC237d
    Blade Air Mobility Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • SEC237d
    Amendment: Blade Air Mobility Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022